Clinical Trial Update: PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update for PhytoSERM aimed at preventing menopause-associated decline in brain metabolism and cognition; the study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Menopause

Drugs mentioned

• PhytoSERM

Snippet

Sponsor: Roberta Brinton | Conditions: Menopause, Cognitive Change | Phase 2 | Status: ACTIVE_NOT_RECRUITING